4//SEC Filing
Tierney David S 4
Accession 0001161697-24-000375
CIK 0001369568other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 5:00 PM ET
Size
9.1 KB
Accession
0001161697-24-000375
Insider Transaction Report
Form 4
Tierney David S
Director
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2024-08-21$4.01/sh+15,000$60,150→ 363,874 total - Sale
Common stock, par value $0.001 per share
2024-08-21$20.10/sh−15,000$301,455→ 348,874 total - Exercise/Conversion
Options to purchase common stock
2024-08-22+15,000→ 188,931 totalExercise: $4.01Exp: 2025-01-02→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $20.00 to $20.485 per share.
- [F3]Options vested in three annual tranches beginning on January 2, 2019.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001292636
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 5:00 PM ET
- Size
- 9.1 KB